More News! For those who want to keep up with everything

More News! 10 Dec 2024

Biotech in 2024: A retrospective

2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?

December 10, 2024 - 14 minutesmins - By Jules Adam

More News! 26 Jul 2024

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

Discover the field of agonistic GPCR antibodies after Confo therapeutics successfully raised $60 million in its series B round.

July 26, 2024 - 8 minutesmins - By Jules Adam

More News! 23 Jul 2024

First AKT-targeting drug capivasertib to hit the market, could it open the door for more?

As AstraZeneca and Astex’s capivasertib gains market presence in breast cancer, could it be the time for AKT inhibitors? Let’s find out!

July 23, 2024 - 7 minutesmins - By Jules Adam

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51.

July 17, 2024 - 10 minutesmins - By Jules Adam

Best in Biotech 12 Jul 2024

Five universities in Canada to build a career in biotech in 2024

Delve into Canada’s biotech education ecosystem with five universities putting industry experience forward.

July 12, 2024 - 8 minutesmins - By Jules Adam

CDMO industry post BIOSECURE Act: Indian CDMOs take WuXi's place

More News! 11 Jul 2024

CDMO trends post-Wuxi’s exit from the US: who will take its place?

The BIOSECURE Act is reshuffling the deck and Indian CDMOs are looking good. Discover the trends in this evolving landscape.

July 11, 2024 - 8 minutesmins - By Jules Adam

More News! 27 May 2024

New report shows that Swiss biotech capital investment surged last year

With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024.

May 27, 2024 - 5 minutesmins - By Jules Adam

Expert Advice 17 May 2024

How to use LinkedIn to ace your biotech job search and advance your career

LinkedIn is the most powerful tool to develop your career in the biotech industry. Delve into the strategies to use it efficiently.

May 17, 2024 - 12 minutesmins - By Jules Adam

In Depth 24 Apr 2024

Overcoming toxicities: are IL-2 smart cytokines the next big thing?

A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.

April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter

More News! 4 Dec 2023

FDA CAR-T cell therapy warning: Are T cells malignant?

Chimeric antigen receptor (CAR) T cell therapies have emerged as groundbreaking treatments for various hematologic cancers, demonstrating remarkable efficacy in targeting specific cancer cells. However, recent concerns raised by the U.S. Food and Drug Administration (FDA) have sparked an investigation into potential risks associated with these therapies. The FDA CAR-T cell therapy warning comes at […]

December 4, 2023 - 4 minutesmins - By Jules Adam

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

Our immune system serves as the body’s chief line of defense against harmful invaders. But what happens when this mighty defense mechanism turns on its own host, launching an assault on healthy cells and tissues? For the millions of people battling autoimmune diseases, this can severely affect their lives. However, advances in immunotherapy have revolutionized […]

June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter

More News! 6 Jun 2023

$5.5M funding for Oncopole to tackle cancer

Oncopole, Fonds de recherche du Québec – Santé (FRQS) cancer division in Canada, has received major investments that boost its public-private partnership model dedicated to the fight against cancer. Oncopole will continue to pursue its mission thanks to a $3 million reinvestment from founding partner Merck Canada. Oncopole, FRQS cancer division, is the result of […]

June 6, 2023 - 4 minutesmins - By Jim Cornall

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

More News!

Biotech in 2024: A retrospective

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

First AKT-targeting drug capivasertib to hit the market, could it open the door for more?

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

Five universities in Canada to build a career in biotech in 2024

CDMO trends post-Wuxi’s exit from the US: who will take its place?

New report shows that Swiss biotech capital investment surged last year

How to use LinkedIn to ace your biotech job search and advance your career

Overcoming toxicities: are IL-2 smart cytokines the next big thing?

FDA CAR-T cell therapy warning: Are T cells malignant?

The promise of immunotherapy for autoimmune diseases

$5.5M funding for Oncopole to tackle cancer

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!